{"id":49123,"date":"2025-11-27T16:13:27","date_gmt":"2025-11-27T08:13:27","guid":{"rendered":"https:\/\/flcube.com\/?p=49123"},"modified":"2025-11-27T16:13:28","modified_gmt":"2025-11-27T08:13:28","slug":"patronus-biotech-gates-foundation-grant-accelerates-malaria-vaccine-development","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=49123","title":{"rendered":"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development"},"content":{"rendered":"\n<p><strong>Patronus Biotech Pte. Ltd.<\/strong> announced it has received a grant from the <strong>Gates Foundation<\/strong> to accelerate development of its <strong>novel malaria vaccine LYB014<\/strong> and low\u2011cost adjuvant <strong>A02<\/strong>, targeting affordable global access to combat <em>Plasmodium falciparum<\/em> infections.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-grant-details\">Grant Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Patronus Biotech Pte. Ltd.<\/td><\/tr><tr><td><strong>Funder<\/strong><\/td><td>Gates Foundation<\/td><\/tr><tr><td><strong>Program<\/strong><\/td><td>LYB014 (U\u2011VLP malaria vaccine) + A02 adjuvant<\/td><\/tr><tr><td><strong>Vaccine Target<\/strong><\/td><td>Multiple stages of <em>Plasmodium falciparum<\/em> life cycle<\/td><\/tr><tr><td><strong>Adjuvant<\/strong><\/td><td>A02: low\u2011cost, high\u2011purity synthetic adjuvant<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Affordable access and use in global health<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-profile\">Technology Profile<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>LYB014:<\/strong> Universal Virus\u2011Like Particle (U\u2011VLP) vaccine targeting <strong>all three critical stages<\/strong> of <em>P. falciparum<\/em> lifecycle<\/li>\n\n\n\n<li><strong>A02 Adjuvant:<\/strong> Synthetic adjuvant system inducing <strong>highly efficient and durable<\/strong> humoral and cellular immunity<\/li>\n\n\n\n<li><strong>Innovation:<\/strong> First vaccine to simultaneously address multiple malaria stages; combined with cost\u2011effective adjuvant<\/li>\n\n\n\n<li><strong>Development Path:<\/strong> Pre\u2011clinical evaluation funded; clinical trials to follow<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-outlook\">Market Context &amp; Outlook<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>Value<\/th><\/tr><\/thead><tbody><tr><td><strong>Global Malaria Cases<\/strong><\/td><td>247\u202fmillion (2022, WHO)<\/td><\/tr><tr><td><strong>Malaria Deaths<\/strong><\/td><td>619,000 annually; 95% in Africa<\/td><\/tr><tr><td><strong>Current Vaccines<\/strong><\/td><td>RTS,S (30% efficacy) and R21\/Matrix\u2011M (70% efficacy) target only sporozoite stage<\/td><\/tr><tr><td><strong>Vaccine Market Size<\/strong><\/td><td>$150\u202fmillion (2024); projected $1.2\u202fbillion by 2030<\/td><\/tr><tr><td><strong>Gates Foundation Role<\/strong><\/td><td>Largest global health funder for malaria; grants typically $10\u201150\u202fmillion for vaccine development<\/td><\/tr><tr><td><strong>Peak Potential<\/strong><\/td><td><strong>$500\u202fmillion\u20111\u202fbillion<\/strong> revenue if approved and adopted by Gavi\/UNICEF<\/td><\/tr><tr><td><strong>Competitive Edge:<\/strong> Multi\u2011stage approach could achieve <strong>&gt;85% efficacy<\/strong>; low\u2011cost adjuvant enables <strong>$2\u20115 per dose<\/strong> pricing target<\/td><td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding Patronus Biotech\u2019s malaria vaccine development, funding utilization, and market potential. Actual results may differ materially due to risks including clinical trial outcomes, manufacturing scale\u2011up, and global procurement dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Patronus Biotech Pte. Ltd. announced it has received a grant from the Gates Foundation to&#8230;<\/p>\n","protected":false},"author":1,"featured_media":49125,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2698,12],"class_list":["post-49123","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-patronus-biotech","tag-vaccine"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Patronus Biotech Pte. Ltd. announced it has received a grant from the Gates Foundation to accelerate development of its novel malaria vaccine LYB014 and low\u2011cost adjuvant A02, targeting affordable global access to combat Plasmodium falciparum infections.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=49123\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development\" \/>\n<meta property=\"og:description\" content=\"Patronus Biotech Pte. Ltd. announced it has received a grant from the Gates Foundation to accelerate development of its novel malaria vaccine LYB014 and low\u2011cost adjuvant A02, targeting affordable global access to combat Plasmodium falciparum infections.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=49123\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-27T08:13:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-27T08:13:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2804.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development\",\"datePublished\":\"2025-11-27T08:13:27+00:00\",\"dateModified\":\"2025-11-27T08:13:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123\"},\"wordCount\":274,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2804.webp\",\"keywords\":[\"Patronus Biotech\",\"Vaccine\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49123#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=49123\",\"name\":\"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2804.webp\",\"datePublished\":\"2025-11-27T08:13:27+00:00\",\"dateModified\":\"2025-11-27T08:13:28+00:00\",\"description\":\"Patronus Biotech Pte. Ltd. announced it has received a grant from the Gates Foundation to accelerate development of its novel malaria vaccine LYB014 and low\u2011cost adjuvant A02, targeting affordable global access to combat Plasmodium falciparum infections.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49123\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2804.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2804.webp\",\"width\":1080,\"height\":608,\"caption\":\"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49123#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development - Insight, China&#039;s Pharmaceutical Industry","description":"Patronus Biotech Pte. Ltd. announced it has received a grant from the Gates Foundation to accelerate development of its novel malaria vaccine LYB014 and low\u2011cost adjuvant A02, targeting affordable global access to combat Plasmodium falciparum infections.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=49123","og_locale":"en_US","og_type":"article","og_title":"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development","og_description":"Patronus Biotech Pte. Ltd. announced it has received a grant from the Gates Foundation to accelerate development of its novel malaria vaccine LYB014 and low\u2011cost adjuvant A02, targeting affordable global access to combat Plasmodium falciparum infections.","og_url":"https:\/\/flcube.com\/?p=49123","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-27T08:13:27+00:00","article_modified_time":"2025-11-27T08:13:28+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2804.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=49123#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=49123"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development","datePublished":"2025-11-27T08:13:27+00:00","dateModified":"2025-11-27T08:13:28+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=49123"},"wordCount":274,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=49123#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2804.webp","keywords":["Patronus Biotech","Vaccine"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=49123#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=49123","url":"https:\/\/flcube.com\/?p=49123","name":"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=49123#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=49123#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2804.webp","datePublished":"2025-11-27T08:13:27+00:00","dateModified":"2025-11-27T08:13:28+00:00","description":"Patronus Biotech Pte. Ltd. announced it has received a grant from the Gates Foundation to accelerate development of its novel malaria vaccine LYB014 and low\u2011cost adjuvant A02, targeting affordable global access to combat Plasmodium falciparum infections.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=49123#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=49123"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=49123#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2804.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2804.webp","width":1080,"height":608,"caption":"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=49123#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2804.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49123"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49123\/revisions"}],"predecessor-version":[{"id":49126,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49123\/revisions\/49126"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/49125"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}